Effect of 5 weeks of oral acetazolamide on patients with pulmonary vascular disease: A randomized, double-blind, cross-over trial

Lichtblau, M.; Saxer, Stéphanie; Müller, J.; Appenzeller, P.; Berlier, C.; Schneider, SR.; Mayer, L.; Furian, M.; Schwarz, El.; Swenson, ER.; Bloch, KE.; Ulrich, S.

doi:10.1016/j.pulmoe.2022.11.004

Zitat wurde kopiert

Lichtblau, M., Saxer, S., Müller, J., Appenzeller, P., Berlier, C., Schneider, SR., Mayer, L., Furian, M., Schwarz, El., Swenson, ER., Bloch, KE., & Ulrich, S. (2024). Effect of 5 weeks of oral acetazolamide on patients with pulmonary vascular disease: A randomized, double-blind, cross-over trial. Pulmonology, 30(4). https://doi.org/10.1016/j.pulmoe.2022.11.004

Zusätzliche Indizierung

Institution	Eastern Switzerland University of Applied Sciences (OST)
Autor:in	Lichtblau, M. Saxer, Stéphanie Müller, J. Appenzeller, P. Berlier, C.
Erschienen in	Pulmonology
Band	30
Ausgabe	4
Datum der Veröffentlichung	2024

Effect of 5 weeks of oral acetazolamide on patients with pulmonary vascular disease: A randomized, double-blind, cross-over trial

Datum

Zusätzliche Indizierung

Metriken

Zitationen